Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Diagnostic Performance and Prognostic Value of PET/CT with Different Tracers for Brain Tumors: A Systematic Review of Published Meta-Analyses.

Treglia G, Muoio B, Trevisi G, Mattoli MV, Albano D, Bertagna F, Giovanella L.

Int J Mol Sci. 2019 Sep 20;20(19). pii: E4669. doi: 10.3390/ijms20194669. Review.

2.

More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.

Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.

PMID:
30843003
3.

Diagnostic Performance of 18F-FDG PET/CT in Infectious and Inflammatory Diseases according to Published Meta-Analyses.

Treglia G.

Contrast Media Mol Imaging. 2019 Jul 25;2019:3018349. doi: 10.1155/2019/3018349. eCollection 2019. Review.

4.

The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review.

Treglia G, Giovannini E, Di Franco D, Calcagni ML, Rufini V, Picchio M, Giordano A.

Ann Nucl Med. 2012 Jul;26(6):451-61. doi: 10.1007/s12149-012-0602-7. Epub 2012 May 8. Review.

PMID:
22566040
5.

Diagnostic performance of PET/CT with tracers other than F-18-FDG in oncology: an evidence-based review.

Treglia G, Sadeghi R, Del Sole A, Giovanella L.

Clin Transl Oncol. 2014 Sep;16(9):770-5. doi: 10.1007/s12094-014-1168-8. Epub 2014 Mar 20. Review.

PMID:
24647843
6.

New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.

Evangelista L, Briganti A, Fanti S, Joniau S, Reske S, Schiavina R, Stief C, Thalmann GN, Picchio M.

Eur Urol. 2016 Jul;70(1):161-175. doi: 10.1016/j.eururo.2016.01.029. Epub 2016 Feb 2. Review.

PMID:
26850970
7.

Diagnostic role of radiolabelled choline PET or PET/CT in hepatocellular carcinoma: a systematic review and meta-analysis.

Bertagna F, Bertoli M, Bosio G, Biasiotto G, Sadeghi R, Giubbini R, Treglia G.

Hepatol Int. 2014 Oct;8(4):493-500. doi: 10.1007/s12072-014-9566-0. Epub 2014 Sep 3.

PMID:
26202754
8.

Diagnostic accuracy of positron emission tomography tracers for the differentiation of tumor progression from treatment-related changes in high-grade glioma: a systematic review and meta-analysis.

de Zwart PL, van Dijken BR, Holtman GA, Stormezand GN, Dierckx RA, van Laar PJ, van der Hoorn A.

J Nucl Med. 2019 Sep 20. pii: jnumed.119.233809. doi: 10.2967/jnumed.119.233809. [Epub ahead of print]

PMID:
31541032
9.

Accuracy of 18F-FDOPA Positron Emission Tomography and 18F-FET Positron Emission Tomography for Differentiating Radiation Necrosis from Brain Tumor Recurrence.

Yu J, Zheng J, Xu W, Weng J, Gao L, Tao L, Liang F, Zhang J.

World Neurosurg. 2018 Jun;114:e1211-e1224. doi: 10.1016/j.wneu.2018.03.179. Epub 2018 Apr 4. Review.

PMID:
29625311
10.

Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis.

Liu F, Zhang Q, Zhu D, Li Z, Li J, Wang B, Zhou D, Dong J.

Medicine (Baltimore). 2015 Sep;94(36):e1462. doi: 10.1097/MD.0000000000001462. Erratum in: Medicine (Baltimore). 2016 Jan;95(2):e187a. Liu, Fengxia [Added]. Medicine (Baltimore). 2016 Jan 15;95(2):e187a.

11.

Current Radiopharmaceuticals for Positron Emission Tomography of Brain Tumors.

Jung JH, Ahn BC.

Brain Tumor Res Treat. 2018 Oct;6(2):47-53. doi: 10.14791/btrt.2018.6.e13. Review.

12.

Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the assessment of pleural abnormalities in cancer patients: a systematic review and a meta-analysis.

Treglia G, Sadeghi R, Annunziata S, Lococo F, Cafarotti S, Prior JO, Bertagna F, Ceriani L, Giovanella L.

Lung Cancer. 2014 Jan;83(1):1-7. doi: 10.1016/j.lungcan.2013.11.002. Epub 2013 Nov 13. Review.

PMID:
24290256
13.

Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis.

Treglia G, Piccardo A, Imperiale A, Strobel K, Kaufmann PA, Prior JO, Giovanella L.

Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):751-765. doi: 10.1007/s00259-018-4123-z. Epub 2018 Aug 9.

PMID:
30094461
14.

Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: A meta-analysis.

Annunziata S, Pizzuto DA, Caldarella C, Galiandro F, Sadeghi R, Treglia G.

World J Gastroenterol. 2015 Oct 28;21(40):11481-8. doi: 10.3748/wjg.v21.i40.11481. Review.

15.
16.
17.

123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Bleeker G, Tytgat GA, Adam JA, Caron HN, Kremer LC, Hooft L, van Dalen EC.

Cochrane Database Syst Rev. 2015 Sep 29;(9):CD009263. doi: 10.1002/14651858.CD009263.pub2. Review.

18.

PET Imaging in Recurrent Medullary Thyroid Carcinoma.

Treglia G, Rufini V, Salvatori M, Giordano A, Giovanella L.

Int J Mol Imaging. 2012;2012:324686. doi: 10.1155/2012/324686. Epub 2012 Jul 18.

19.

Effectiveness of 18F-FDG PET/CT in the diagnosis and staging of osteosarcoma: a meta-analysis of 26 studies.

Liu F, Zhang Q, Zhou D, Dong J.

BMC Cancer. 2019 Apr 5;19(1):323. doi: 10.1186/s12885-019-5488-5.

20.

Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography in patients with chronic inflammatory bowel disease: a systematic review and a meta-analysis.

Treglia G, Quartuccio N, Sadeghi R, Farchione A, Caldarella C, Bertagna F, Fania P, Cistaro A.

J Crohns Colitis. 2013 Jun;7(5):345-54. doi: 10.1016/j.crohns.2012.08.005. Epub 2012 Sep 7. Review.

Supplemental Content

Support Center